Orilissa Tablet, Film Coated
Pricing Report NDC 0074-0038-01

Latest NADAC: $39.77023 per EA · Effective Oct 23, 2024

Current Package Pricing Information

The latest wholesale acquisition cost for Orilissa (NDC 0074-0038-01) is $39.77023 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Oct 23, 2024.

As a a human prescription drug provided by Abbvie Inc., this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$39.77023
Per EA

Effective Date
Oct 23, 2024
Data Status
As of Oct 30, 2024
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jan 2019, the NADAC wholesale price for (NDC ) has moved within a range of $28.98091 to $43.81958 per EA. Over this 7 years and 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$28.9809 - $43.8196
Market Volatility
51.20% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $43.80871 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $43.81958 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $43.80217 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $43.80230 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $43.77758 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 02, 2026 $43.79038 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Jan 02, 2026 $43.79038 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Jan 02, 2026 $43.79038 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Dec 17, 2025 $41.70512 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $41.71005 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $41.70865 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $41.74778 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026